| Quarter (USD) | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 290.15 mm | 290.15 mm | 290.15 mm | 290.15 mm | 290.15 mm | 290.15 mm |
| Cash burn (monthly) | 6.46 mm | 11.33 mm | 41.45 mm | 28.72 mm | 35.10 mm | 21.62 mm |
| Cash used (since last report) | 208.78 mm | 365.92 mm | 1.34 bn | 927.85 mm | 1.13 bn | 698.58 mm |
| Cash remaining | 81.36 mm | -75.78 mm | -1.05 bn | -637.71 mm | -843.96 mm | -408.44 mm |
| Runway (months of cash) | 12.6 | -6.7 | -25.3 | -22.2 | -24.0 | -18.9 |
| 13F holders | Current |
|---|---|
| Total holders | 1 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 230.27 mm |
| Total shares | 2.27 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| GSK GSK | 2.27 mm | $230.27 mm |
